Paul Bleicher, MD, PhD is a leading expert in clinical trial/clinical development informatics, predictive analytics, data visualization and the application of machine learning and artificial intelligence to the analysis of aggregated EHR and claims healthcare data to understand cost, quality, and outcomes of medical care.
Previously he was CEO of OptumLabs, CMO of Humedica, and founder and CEO of Phase Forward. He is currently an Executive Partner at Ardan Equity.
